A) Different FN recombinant fragments tested with the mAb C6. B) Reactivity in ELISA of various concentrations of the mAb C6 with the FN recombinant fragment containing the type III repeats B and 8; i
This study explored the potential use of NA as an immunogen for next-generation influenza vaccines by characterizing a vaccine-induced broadly protective monoclonal antibody (mAb) targeting NA.
Immunology Database and Analysis Portal2025-10-30 更新30
We employed an inhibition-type enzyme-linked immunosorbent assay (ELISA) to characterize a murine immunoglobulin M monoclonal antibody (MAb) that bound soluble macromolecular peptidoglycan (PG). With
Results from extensive characterization of the antibodies in a variety of other assay formats. "Reagents" tab lists antibody identifiers found on antibodies.cancer.gov and catalog numbers for recombin
